Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Mar 9;7(6):e006906.
doi: 10.1161/JAHA.117.006906.

Advances in the Understanding of the Genetic Determinants of Congenital Heart Disease and Their Impact on Clinical Outcomes

Affiliations
Review

Advances in the Understanding of the Genetic Determinants of Congenital Heart Disease and Their Impact on Clinical Outcomes

Mark W Russell et al. J Am Heart Assoc. .
No abstract available

Keywords: clinical outcomes; congenital heart defects; genetics.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Factors affecting neurodevelopmental outcomes. Measured neurodevelopmental outcomes are directly influenced by how the brain has been formed and developed (brain development), whether or not it has been injured during development or perioperatively (brain injury), and how it has been affected by the patient's social and educational environment (social and educational factors). Genetic factors can have a primary effect on brain development. They can also have a secondary or modifying effect (red arrows) on other factors that affect brain structure and function, including hemodynamic factors, hypoxic/ischemic injury, and drug/toxin‐mediated effects.
Figure 2
Figure 2
Genetic determinants of congenital heart defects. The majority of congenital heart defects do not have an identified genetic etiology. Unexplained CHD may be secondary to noncoding genetic, epigenetic, and environmental factors, among others. All estimates are approximate and are based on recent publications.20, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40 CNVs indicates copy number variants.

References

    1. van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ, Roos‐Hesselink JW. Birth prevalence of congenital heart disease worldwide: a systematic review and meta‐analysis. J Am Coll Cardiol. 2011;58:2241–2247. - PubMed
    1. Tutar E, Ekici F, Atalay S, Nacar N. The prevalence of bicuspid aortic valve in newborns by echocardiographic screening. Am Heart J. 2005;150:513–515. - PubMed
    1. Jacobs JP, O'Brien SM, Pasquali SK, Jacobs ML, Lacour‐Gayet FG, Tchervenkov CI, Austin EH III, Pizarro C, Pourmoghadam KK, Scholl FG, Welke KF, Mavroudis C. Variation in outcomes for benchmark operations: an analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database. Ann Thorac Surg. 2011;92:2184–2191. - PMC - PubMed
    1. Jacobs ML, O'Brien SM, Jacobs JP, Mavroudis C, Lacour‐Gayet F, Pasquali SK, Welke K, Pizarro C, Tsai F, Clarke DR. An empirically based tool for analyzing morbidity associated with operations for congenital heart disease. J Thorac Cardiovasc Surg. 2013;145:1046–1057. - PMC - PubMed
    1. Vogt KN, Manlhiot C, Van Arsdell G, Russell JL, Mital S, McCrindle BW. Somatic growth in children with single ventricle physiology impact of physiologic state. J Am Coll Cardiol. 2007;50:1876–1883. - PubMed

Publication types

Substances

LinkOut - more resources